
SR146131
CAS No. 221671-61-0
SR146131 ( SR-146131 | SR 146131 )
产品货号. M13535 CAS No. 221671-61-0
SR146131 (SR-146131) 一种 1 型胆囊收缩素受体 (CCK1R) 的小分子正变构调节剂,pEC50 为 10.34。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥5654 | 有现货 |
![]() ![]() |
25MG | ¥12393 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称SR146131
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SR146131 (SR-146131) 一种 1 型胆囊收缩素受体 (CCK1R) 的小分子正变构调节剂,pEC50 为 10.34。
-
产品描述SR146131 (SR-146131) a small molecule positive allosteric modulator of the type 1 cholecystokinin receptor (CCK1R) with pEC50 of 10.34.
-
体外实验SR 146131 inhibits in the binding of [125I]-BH-CCK-8S to CCK1sites on 3T3-hCCK1 cell membranes with an IC50 value of 0.56 ± 0.10 nM. At much higher concentrations, SR 146131 also inhibits the binding of radiolabeled CCK to CCK2sites in CHO-hCCK2 membranes with an IC50 of 162 ± 27 nM. SR 146131 is a potent CCK1 agonist on several intracellular events linked to CCK1 receptor activation in various cell types: on [Ca2+]i release and IP1 formation, SR 146131 appears as a full CCK1 receptor agonist in the 3T3-hCCK1 cells, but a partial CCK1receptor agonist on MAPK activation and early gene expression in this cell line. SR 146131 also acts as a partial agonist in the two neuroblastoma cell lines.
-
体内实验SR 146131 completely inhibits gastric and gallbladder emptying in mice (ED50 of 66 and 2.7 μg/kg p.o., respectively). SR 146131 dose dependently reduces food intake in fasted rats (from 0.1 mg/kg p.o.), in nonfasted rats in which food intake has been highly stimulated by the administration of neuropeptide Y (1–36) (from 0.3 mg/kg p.o.), in fasted gerbils (from 0.1 mg/kg p.o.), and in marmosets maintained on a restricted diet (from 3 mg/kg p.o.). SR 146131 (10 mg/kg p.o.) also increases the number of Fos-positive cells in the hypothalamic paraventricular nucleus of rats. Locomotor activity of mice is reduced by orally administered SR 146131 (from 0.3 mg/kg p.o.).
-
同义词SR-146131 | SR 146131
-
通路GPCR/G Protein
-
靶点Cholecystokinin Receptor
-
受体Cholecystokinin Receptor
-
研究领域Metabolic Disease
-
适应症——
化学信息
-
CAS Number221671-61-0
-
分子量610.166
-
分子式C32H36ClN3O5S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 250 mg/mL (409.73 mM)
-
SMILESO=C(O)CN1C(C(NC2=NC(C3=CC(OC)=C(Cl)C=C3OC)=C(CCC4CCCCC4)S2)=O)=CC5=C1C(C)=CC(C)=C5
-
化学全称2-(2-((4-(4-chloro-2,5-dimethoxyphenyl)-5-(2-cyclohexylethyl)thiazol-2-yl)carbamoyl)-5,7-dimethyl-1H-indol-1-yl)acetic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Desai AJ, et al. Mol Pharmacol. 2018 Dec 27. pii: mol.118.114082. doi: 10.1124/mol.118.114082.
产品手册




关联产品
-
L-365260
一种有效的、选择性的、口服活性的胆囊收缩素受体 2 (CCK2) 拮抗剂,IC50 为 2 nM。
-
Methyl Linoleate
亚油酸甲酯具有抗氧化活性。
-
Lorglumide sodium sa...
Lorglumideodium salt 是一种有效的胆囊收缩素 (CCK) 受体拮抗剂。